[ad_1]
A mix of ingredients at a Baltimore manufacturing plant ruined 15 million doses of the Johnson & Johnson COVID-19 vaccine, The New York Times reported. This could delay future shipments of this vaccine to the United States.
There is no problem with the doses of the Johnson & Johnson vaccine that have already been dispensed – these were produced in the Netherlands, the Times reported. But the tens of millions of snaps that were due to ship in April were supposed to come from that Baltimore factory.
The manufacturing plant, run by Emergent BioSolutions, received $ 628 million from the Trump administration last year to expand its vaccine manufacturing capacity. The factory was still awaiting approval from the Food and Drug Administration for its Johnson & Johnson vaccine production lines, and this huge mistake – which Times sources attributed to human error – will likely delay even further. It is not known how this setback will affect the availability of this vaccine over the next few weeks.
Moderna and Pfizer / BioNTech are still on track to meet their vaccine commitments in the United States, which should give the country enough doses to meet the Biden administration’s goal of having vaccines available for each. adult by the end of May.
But the limited availability of the Johnson & Johnson vaccine could still hamper US efforts to vaccinate enough people for herd immunity. People who are reluctant to get vaccinated against COVID-19 and say they will “wait and see” are more likely to agree to take the Johnson & Johnson vaccine than the Pfizer / BioNTech or Moderna injections. The Johnson & Johnson vaccine takes only one dose and is made using a more familiar technique. Only the fact of offering the Pfizer / BioNTech and Moderna injections could complicate the task of convincing some people to be vaccinated.
So far, about 30% of the U.S. population has received at least one dose of a COVID-19 vaccine.
[ad_2]
Source link